MEDINCELL S.A.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-06-16
Analyst
Kepler Cheuvreux
Equibles does not estimate personal net worth.
Nicolas Pouillac is recorded as Analyst at Kepler Cheuvreux. Nicolas Pouillac has spoken on 1 earnings call across 1 company, most recently for MEDINCELL S.A. on June 16, 2026. The companies whose calls Nicolas Pouillac spoke on are classified in the Healthcare sector.
“Maybe just a quick question from my hand, too. Just first to come back on a previous question about the kind of gap there is between Teva's guidance on the potential of the two drugs and what you kind of implied, like the blockbuster potential for EZD, for instance.”
Kepler Cheuvreux
Analyst
Transcript header (unverified)
MEDINCELL S.A.
Biotechnology · Healthcare
Videoconference • Annual results 2025-26
MEDINCELL S.A.